Gila GLP-1 & Weight Loss Newsletter - Issue #41

[Psychology Today]💡 **Beyond Food Noise:** Get ready for a mind-blower! New case reports suggest GLP-1 medications might do more than just quiet food cravings – they could also reduce compulsive urges behind Body-Focused Repetitive Behaviors (BFRBs) like hair pulling and skin picking. This fascinating potential points to GLP-1s impacting broader reward and impulse control pathways in our brains, hinting at even more surprising benefits for us all!

[Psychology Today]💡 **More Than Just the Med!** Psychology Today reveals that lasting success with GLP-1s is deeply tied to *how* we approach our journey, not just the medication itself. It emphasizes that ongoing education, strong self-efficacy, and robust support systems are absolutely crucial for long-term adherence and truly transforming our health. Remember, your GLP-1 is a tool, and we're building the whole toolkit together!

[Gila]✈️ **Travel Smart, Stay On Track!** Planning a trip with your GLP-1? This essential guide helps you confidently navigate everything from understanding your pen's storage limits and breezing through airport security, to strategically packing small habits. We love how it turns coming home into a perfect opportunity to intentionally rebuild your routine, keeping your progress strong!

[Gila]🍽️ **Dining Out, Stress-Free!** Eating out on GLP-1 can feel like a challenge, and our latest article reveals it's a documented effect of social eating, not a personal failing! We arm you with smart strategies – from pre-planning your order to having a friendly comeback for "just one more" – so you can enjoy every social meal with confidence and ease.

[Gila]💧 **Hydration Hack:** On GLP-1s, staying properly hydrated is a double challenge – less water from food and potential fluid loss from side effects. Don't wait for thirst! Let's proactively build a routine by tying water intake to your existing daily habits, safeguarding your health and keeping you energized!

[Google News: GLP-1]❤️ **Medicare Impact!** Eli Lilly's CEO shared that a whopping 700,000 new seniors have started GLP-1s after Medicare coverage, with 70% choosing Lilly's medications. This fantastic news shows us the incredible expanding access and growing recognition of these powerful tools, proving that age is just a number when it comes to taking charge of our health and feeling our best!

[Peter Attia]🧬 **Anti-Aging Alert:** Peter Attia's team just dropped a fascinating update on a new study showing semaglutide extended the lifespan and improved multiple aging markers in female mice! While this is early preclinical research, it's incredibly exciting and suggests GLP-1s might have benefits far beyond weight loss, hinting at a potential role in slowing biological aging processes. This gives us another compelling reason to follow the science on these amazing medications!